⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Theravance Biopharma, Inc.

$16.92
-0.01 (-0.06%)

Market Capitalization:

$872.28M

Theravance Biopharma Price Chart

Theravance Biopharma Price Chart2:30 PM3:50 PM5:10 PM6:30 PM7:50 PM5:09 AM6:29 AM16.9416.9416.9316.9316.9316.9216.92

Theravance Biopharma Volume Chart

Theravance Biopharma Volume Chart2:30 PM3:50 PM5:10 PM6:30 PM7:50 PM5:09 AM6:29 AM46.68K40.01K33.34K26.67K20.00K13.34K6.67K

Theravance Biopharma Market Segments

Premarket

*No Trades in Segment

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$16.92
Close$16.92
Low$16.92
Low Change0.00 (0.00%)
High$16.92
High Change+0.00 (+0.00%)
Range$0.00
Volume46.676K
Dollar Volume$789.76K

Regular Trading Hours Yesterday

+0.03(+0.18%)
Open$16.90
Close$16.93
Low$16.90
Low Change0.00 (0.00%)
High$16.94
High Change+0.04 (+0.24%)
Range$0.04
Volume210.969K
Dollar Volume$3.57M

Premarket Yesterday

*No Trades in Segment

Theravance Biopharma Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Theravance Biopharma Moving Averages

5 Day Moving Average (SMA5)$16.89
10 Day Moving Average (SMA10)$16.88
20 Day Moving Average (SMA20)$16.89
50 Day Moving Average (SMA50)$16.74
100 Day Moving Average (SMA100)$16.43
200 Day Moving Average (SMA200)$17.11

Theravance Biopharma Statistics

Average Volume (30 Days)788.93K
P/E Ratio (Current)7.65
EPS (Current)$2.21
Dividend Yield0.00%
Free Cash Flow$268.74M
Cash Ratio4.46
Current Ratio6.47
Quick Ratio6.47
Debt to Equity0.01
Enterprise Value$590.19M
EV to EBITDA89.76
EV to Sales5.38
Price to Book3.01
Price to Cash Flow3.26
Price to Free Cash Flow3.26
Price to Sales7.98
Return on Assets0.24%
Return on Equity0.39%

Theravance Biopharma Stock Splits

There have been no stock splits for Theravance Biopharma (TBPH).

Theravance Biopharma Dividends

There have been no dividends for Theravance Biopharma (TBPH).